About this Journal Submit a Manuscript Table of Contents
Experimental Diabetes Research
Volume 2012 (2012), Article ID 413782, 6 pages
http://dx.doi.org/10.1155/2012/413782
Research Article

The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese

1Division of Endocrinology and Metabolism, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan
2Graduate Institute of Integrated Medicine, China Medical University, Taiwan
3Department of Public Health, Kaohsiung Medical University, Kaohsiung, Taiwan
4School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan
5Department of Internal Medicine, National Taiwan University College of Medicine, No. 7 Chung-Shan South Road, Taipei 100, Taiwan

Received 24 February 2012; Accepted 2 April 2012

Academic Editor: Chien-Jen Chen

Copyright © 2012 Ming-Chia Hsieh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [21 citations]

The following is the list of published articles that have cited the current article.

  • Xiang-Ju Long, Shan Lin, Ya-Nan Sun, and Zhen-Feng Zheng, “Diabetes Mellitus and Prostate Cancer Risk in Asian Countries: a Meta-analy sis,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 8, pp. 4097–4100, 2012. View at PublisherView at Google Scholar
  • Shu-Yi Wang, Chieh-Sen Chuang, Chih-Hsin Muo, Shih-Te Tu, Ming-Chia Lin, and Fung-Chang Sung, “Metformin and the Incidence of Cancer in Patients With Diabetes: A Nested C ase-Control Study,” Diabetes Care, vol. 36, no. 9, pp. E155–E156, 2013. View at PublisherView at Google Scholar
  • Masato Kasuga, Kohjiro Ueki, Naoko Tajima, Mitsuhiko Noda, Ken Ohashi, Hiroshi Noto, Atsushi Goto, Wataru Ogawa, Ryuichi Sakai, Shoichiro Tsugane, Nobuyuki Hamajima, Hitoshi Nakagama, Kazuo Tajima, Kohei Miyazono, and Kohzoh Imai, “Report of the Japan Diabetes Society/Japanese Cancer Association joint committee on diabetes and cancer,” Cancer Science, vol. 104, no. 7, pp. 965–976, 2013. View at PublisherView at Google Scholar
  • Masato Kasuga, Kohjiro Ueki, Naoko Tajima, Mitsuhiko Noda, Ken Ohashi, Hiroshi Noto, Atsushi Goto, Wataru Ogawa, Ryuichi Sakai, Shoichiro Tsugane, Nobuyuki Hamajima, Hitoshi Nakagama, Kazuo Tajima, Kohei Miyazono, and Kohzoh Imai, “Report of the JDS/JCA Joint Committee on Diabetes and Cancer,” Diabetology International, vol. 4, no. 2, pp. 81–96, 2013. View at PublisherView at Google Scholar
  • Jung-Yun Lee, Inpyo Jeon, Joo Myung Lee, Jae-Moon Yoon, and Sang Min Park, “Diabetes mellitus as an independent risk factor for lung cancer: A meta-analysis of observational studies,” European Journal of Cancer, vol. 49, no. 10, pp. 2411–2423, 2013. View at PublisherView at Google Scholar
  • Emmanuel Beck, and André J. Scheen, “Quels bénéfices antitumoraux attendre de la metformine ?,” Annales d'Endocrinologie, vol. 74, no. 2, pp. 137–147, 2013. View at PublisherView at Google Scholar
  • Hiroshi Noto, Atsushi Goto, Tetsuro Tsujimoto, Keiichiro Osame, and Mitsuhiko Noda, “Latest insights into the risk of cancer in diabetes,” Journal of Diabetes Investigation, vol. 4, no. 3, pp. 225–232, 2013. View at PublisherView at Google Scholar
  • Chin-Hsiao Tseng, “Diabetes and thyroid cancer mortality: a 12-year prospective follow-up of Taiwanese,” European Journal of Clinical Investigation, vol. 43, no. 6, pp. 595–601, 2013. View at PublisherView at Google Scholar
  • Chin-Hsiao Tseng, “Diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan,” Acta Diabetologica, 2013. View at PublisherView at Google Scholar
  • Chin-Hsiao Tseng, “Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes,” Annals of Medicine, vol. 45, no. 8, pp. 539–544, 2013. View at PublisherView at Google Scholar
  • Jin Ha Lee, and Tae Il Kim, “Type II Diabetes, Metformin Use, and Colorectal Neoplasia: Mechanisms of Action and Implications for Future Research,” Current Colorectal Cancer Reports, 2013. View at PublisherView at Google Scholar
  • Ao Sun, Rui Liu, and Guangshan Sun, “Insulin therapy and risk of colorectal cancer: an updated meta-analysis of epidemiological studies,” Current Medical Research and Opinion, pp. 1–8, 2013. View at PublisherView at Google Scholar
  • Yan-bo Chen, Qi Chen, and Juan Zhou, “Insulin Therapy and Risk of Prostate Cancer: a Systematic Review and Meta-A nalysis of Observational Studies,” Plos One, vol. 8, no. 11, 2013. View at PublisherView at Google Scholar
  • Ramona Crişan, Mihaela Aldea, and Gabriel Kacso, “It's time for new treatments in pancreatic cancer pathology,” Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, vol. 20, no. 1, pp. 69–75, 2013. View at PublisherView at Google Scholar
  • Hala Ahmadieh, and Sami T. Azar, “Type 2 Diabetes Mellitus, Oral Diabetic Medications, Insulin Therapy, and Overall Breast Cancer Risk,” ISRN Endocrinology, vol. 2013, pp. 1–8, 2013. View at PublisherView at Google Scholar
  • Takumi Kawaguchi, Motoyuki Kohjima, Tatsuki Ichikawa, Masataka Seike, Yasushi Ide, Toshihiko Mizuta, Koichi Honda, Kazuhiko Nakao, Makoto Nakamuta, and Michio Sata, “The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey,” Journal of Gastroenterology, 2014. View at PublisherView at Google Scholar
  • Z.-J. Zhang, Y. Bi, S. Li, Q. Zhang, G. Zhao, Y. Guo, and Q. Song, “Reduced Risk of Lung Cancer With Metformin Therapy in Diabetic Patients: A Systematic Review and Meta-Analysis,” American Journal of Epidemiology, 2014. View at PublisherView at Google Scholar
  • Zheng Wang, Song-tao Lai, Li Xie, Jian-dong Zhao, Ning-yi Ma, Ji Zhu, Zhi-gang Ren, and Guo-liang Jiang, “Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: A systematic review and meta-analysis,” Diabetes Research and Clinical Practice, 2014. View at PublisherView at Google Scholar
  • S. E. Holden, and C. J. Currie, “Mortality risk with sulphonylureas compared to metformin,” Diabetes, Obesity and Metabolism, 2014. View at PublisherView at Google Scholar
  • Chin-Hsiao Tseng, “Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes,” Acta Diabetologica, 2014. View at PublisherView at Google Scholar
  • Farn-Hsuan Tseng, “Diabetes and gastric cancer: the potential links,” World Journal of Gastroenterology, vol. 20, no. 7, pp. 1701–1711, 2014. View at PublisherView at Google Scholar